World's Best Scientists 2026 revealed!
Award Badge
Neuroscience
Denmark
2026

D-Index & Metrics

Medicine

D-Index
92
Citations
32873
World Ranking
11264
National Ranking
120

Neuroscience

D-Index
92
Citations
32401
World Ranking
1021
National Ranking
7

Messoud Ashina publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Messoud Ashina sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 504 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Messoud Ashina D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Messoud Ashina sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 92 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Neuroscience in Denmark Leader Award
  • 2025 - Research.com Neuroscience in Denmark Leader Award

Overview

Messoud Ashina is affiliated with the University of Copenhagen in Denmark. Their research predominantly focuses on medical and neurological sciences, particularly in the study of migraine and headache disorders.

The scientist's recent publications include detailed examinations of migraine and its management. Notable papers authored or co-authored by Ashina are:

  • Migraine, 2020, New England Journal of Medicine
  • Migraine: epidemiology and systems of care, 2021, The Lancet
  • Diagnosis and management of migraine in ten steps, 2021, Nature Reviews Neurology
  • Migraine, 2022, Nature Reviews Disease Primers
  • European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update, 2022, The Journal of Headache and Pain

Their co-authorship network includes several frequent collaborators such as Håkan Ashina, Faisal Mohammad Amin, Mohammad Al-Mahdi Al-Karagholi, Haidar M. Al-Khazali, and Patricia Pozo-Rosich. These collaborations suggest a focus on neurology and specialized headache research.

Messoud Ashina publishes commonly in the following venues:

  • Cephalalgia
  • The Journal of Headache and Pain
  • Headache The Journal of Head and Face Pain
  • Neurology
  • Pain

Their body of work covers the main field of Medicine, with detailed contributions across several subfields, including Psychiatry and Mental Health, Pathology and Forensic Medicine, Physiology, Neurology, and Cellular and Molecular Neuroscience.

Key topics covered in the research include:

  • Migraine and Headache Studies
  • Trigeminal Neuralgia and Treatments
  • Sympathectomy and Hyperhidrosis Treatments
  • Ophthalmology and Eye Disorders
  • Neuropeptides and Animal Physiology
  • Neuroscience of Respiration and Sleep
  • Olfactory and Sensory Function Studies

Best Publications

  • Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

    Stewart Tepper;Messoud Ashina;Uwe Reuter;Jan L Brandes

  • Migraine: epidemiology and systems of care

    Messoud Ashina;Zaza Katsarava;Thien Phu Do;Dawn C Buse

  • Origin of pain in migraine: evidence for peripheral sensitisation.

    Jes Olesen;Rami Burstein;Messoud Ashina;Peer Tfelt-Hansen

  • Migraine and the trigeminovascular system-40 years and counting

    Messoud Ashina;Jakob Møller Hansen;Thien Phu Do;Agustin Melo-Carrillo

  • Migraine

    Unknown

  • ARISE: A Phase 3 randomized trial of erenumab for episodic migraine:

    David W Dodick;Messoud Ashina;Jan Lewis Brandes;David Kudrow

  • PACAP38 induces migraine-like attacks in patients with migraine without aura.

    Henrik Winther Schytz;Steffen Birk;Troels Wienecke;Christina Kruuse

  • European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

    Unknown

  • Diagnosis and management of migraine in ten steps

    Anna K. Eigenbrodt;Håkan Ashina;Sabrina Khan;Hans-Christoph Diener

  • Calcitonin Gene-Related Peptide Triggers Migraine-Like Attacks in Patients With Migraine With Aura

    Jakob Møller Hansen;Anne Werner Hauge;Jes Olesen;Messoud Ashina

  • Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

    David W Dodick;Peter J Goadsby;Peter J Goadsby;Stephen D Silberstein;Richard B Lipton

  • A systematic comparison of motion artifact correction techniques for functional near-infrared spectroscopy

    Robert J. Cooper;Juliette Selb;Louis Gagnon;Dorte Phillip

  • Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.

    Michel D Ferrari;Hans Christoph Diener;Xiaoping Ning;Maja Galic

  • Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

    Hong Sun;David William Dodick;Stephen Silberstein;Peter J. Goadsby

  • Migraine and structural changes in the brain A systematic review and meta-analysis

    Asma Bashir;Richard B. Lipton;Sait Ashina;Messoud Ashina

  • Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.

    Cristina Tassorelli;Hans-Christoph Diener;David W Dodick;Stephen D Silberstein

  • European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

    Simona Sacco;Lars Bendtsen;Messoud Ashina;Uwe Reuter

  • Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).

    Messoud Ashina;Joel Saper;Roger Cady;Barbara A Schaeffler

  • Evidence for a vascular factor in migraine

    Mohammad S. Asghar;Adam E. Hansen;Faisal M. Amin;R. J. van der Geest

  • Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study

    Faisal Mohammad Amin;Mohammad Sohail Asghar;Anders Hougaard;Adam Espe Hansen

  • Nitric oxide synthase inhibition in migraine

    LH Lassen;M Ashina;I Christiansen;V Ulrich

  • Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine.

    A Rahmann;A Rahmann;T Wienecke;JM Hansen;J Fahrenkrug

Frequent Co-Authors

Jes Olesen
Jes Olesen University of Copenhagen
Henrik Larsson
Henrik Larsson Karolinska Institute
Rigmor Jensen
Rigmor Jensen University of Copenhagen
Peter J. Goadsby
Peter J. Goadsby King's College London
Stephen D. Silberstein
Stephen D. Silberstein Thomas Jefferson University
David W. Dodick
David W. Dodick Mayo Clinic
Richard B. Lipton
Richard B. Lipton Albert Einstein College of Medicine
Hans-Christoph Diener
Hans-Christoph Diener University of Duisburg-Essen
Stewart J. Tepper
Stewart J. Tepper Dartmouth College
Olaf B. Paulson
Olaf B. Paulson University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying neuroscience in the USA opens a range of online degree options and career pathways in mental health, research, and counseling. Many students explore related programs that offer flexibility, affordability, or specialized credentials to enhance their career prospects.

If you're seeking a cost-effective alternative, consider a cheap online psychology degree. This pathway provides a solid foundation in behavioral science and can lead to multiple career options in healthcare and human services.

Those interested in clinical practice or therapy might consider mft programs online for marriage and family therapy, or look into APA-accredited online psyd programs apa accredited to become a practicing psychologist. Both pathways require advanced training but offer significant employment opportunities.

For students wanting a fast-track to licensed social work, an accelerated 1 year online master's in social work offers the chance to enter the field quickly. Each of these online options can complement or enhance a neuroscience background, broadening both career choices and impact.

Best Scientists Citing Messoud Ashina

Trending Scientists

Recently Published Articles